Type IV pili decreases in ARC6851 under colistin and diclofenac combination treatment. by Fabiana Bisaro (20308955)

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

S1 Data. Bibliometric analysis. S2 Data. Estrogen level analysis. S3 Data. MicroCT quantification. S4 Data. Markers of bone metabolism. by Yan She (8639796)

The 39 differentially expressed proteins (DEPs) were capable of distinguishing different degrees of muscle injury and their fold changes. by Huiyang Jia (14444661)

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... by Jinho Lee (587173)

The 160 differentially expressed proteins significantly elevated in the severe injury group compared to the mild injury group and their folding changes. by Huiyang Jia (14444661)

Contents of chlorophyll a, chlorophyll b (Chl a, Chl b) and carotenoid in <i>D</i>. <i>parva</i> cells under treatment of various concentrations of MeJA and GA3. by Lingru Ruan (18995544)

HA-MAD1 tumors have increased CIN and decreased p53. by Sarah E. Copeland (13951506)

Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. by Jennifer M. Kwan (3350321)

Fold change in clone size for large clones after ART. by Marco Garcia Noceda (22250847)

Actin-Targeted Magnetic Nanomotors Mechanically Modulate the Tumor Mechanical Microenvironment for Cancer Treatment by Xing Fan (88299)

Summary of treatment groups and regimens. by Denise Evans (288201)

Subjects:

Normalized sample plots for each treatment for data quality control. by Caijin Chen (3107787)

Skin marks is the S1 Fig title. by Mercedes Soto-González (20422078)

Analysis of apoptotic cells within the vocal fold muscle following DFATs transplantation. by Ikuo Mikoshiba (9312007)

The values approximated and calculated for and for the WT and each mutant Abl1 enzyme. by J. Roadnight Sheehan (20141887)

Subjects:

A visual comparison of the associated resistance data from Table 1 with the values of <i>k</i>_cat, <i>K</i>_M, catalytic efficiency (<i>k</i>_cat/<i>... by J. Roadnight Sheehan (20141887)

Subjects:

The values for <i>k</i>_cat and <i>K</i>_M are sourced from [19]. by J. Roadnight Sheehan (20141887)

Subjects:

The values for and with the resultant ΔΔ<i>G</i>_Mut, found through FEP simulations. ΔΔ<i>G</i>_Mut for the wild-type is 0 kcal/mol. by J. Roadnight Sheehan (20141887)

Subjects:

The table (refined data from [14]) shows the mutants associated with resistance for imatinib, ponatinib, and dasatinib. by J. Roadnight Sheehan (20141887)

Subjects: